# Efficiency of Presurgical Basal Cell Carcinoma Margin Mapping

> **NCT03420846** · NA · TERMINATED · sponsor: **Michelson Diagnostics Ltd.** · enrollment: 86 (actual)

## Conditions studied

- Carcinoma, Basal Cell

## Interventions

- **OTHER:** OCT Mapped

## Key facts

- **NCT ID:** NCT03420846
- **Lead sponsor:** Michelson Diagnostics Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-07-01
- **Primary completion:** 2019-09-01
- **Final completion:** 2019-09-01
- **Target enrollment:** 86 (ACTUAL)
- **Why stopped:** Funding exhausted. Sufficient data already collected.
- **Last updated:** 2020-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03420846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03420846, "Efficiency of Presurgical Basal Cell Carcinoma Margin Mapping". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03420846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*